How can I repair pitted acne scars and enlarged pores?

Atrophic acne scars—commonly referred to as “acne pits” or “icepick,” “boxcar,” or “rolling” scars—often coexist with enlarged pores, particularly in individuals with a history of inflammatory acne and oily or sebaceous skin. These structural changes result from collagen loss and dermal remodeling following acne-induced inflammation and tissue damage. While pores themselves do not “enlarge” permanently in the strictest anatomical sense (pore size is genetically determined), chronic inflammation, sebum accumulation, follicular dilation, and loss of surrounding dermal support can create the clinical appearance of pore enlargement.

Effective management requires a multimodal approach tailored to scar morphology, skin type, and patient goals. For atrophic scarring, evidence-based interventions include fractional laser resurfacing (e.g., ablative CO₂ or non-ablative 1550-nm erbium-doped fiber lasers), microneedling with radiofrequency (RF-microneedling), and chemical reconstruction of skin scars (CROSS) using high-concentration trichloroacetic acid for deep icepick scars. Subcision may be indicated for tethered rolling scars. All these modalities stimulate neocollagenesis and dermal regeneration over multiple treatment sessions spaced 4–8 weeks apart.

For apparent pore enlargement, adjunctive strategies focus on optimizing epidermal turnover and sebaceous regulation: topical retinoids (e.g., tretinoin or adapalene) improve keratinocyte differentiation and reduce follicular plugging; niacinamide (4–5%) helps regulate sebum production and strengthen the epidermal barrier; and gentle, non-comedogenic cleansers and sunscreen (broad-spectrum SPF 30+) are essential for maintaining results and preventing further photodamage or post-inflammatory sequelae.

It’s critical to emphasize that realistic expectations and consistent follow-up are key. Significant improvement typically requires 3–6 treatment sessions for scarring, alongside 3–6 months of daily topical therapy for pore appearance. Patients with active acne must achieve disease control first—often with oral antibiotics, hormonal therapy (e.g., spironolactone or combined oral contraceptives in appropriate candidates), or isotretinoin—before initiating scar revision, as ongoing inflammation undermines treatment efficacy and increases complication risk.